rituximab,ibrutinib,bendamustine
roche,biogen,abbvie,janssen,teva
['rituximab', 'ibru']
the combination of ibrutinib plus the chemotherapy bendamustine and rituximab immunotherapy elicited the highest pfs rate ever reported for this patient population, according to an expert. #mcl #asco22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.